CANCER 2026 Elanor Wainwright
Peter MacCallum Cancer Centre, VICTORIA, Australia
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemia (131781)
2:40 PM
Shellaina JV Gordon
Session 1: Stem Cells and Leukaemia
Temporal single clone analyses reveal a Xlr4b driven HSPC program that facilitates T-cell reconstitution following transplantation. (#270)
5:35 PM
Elanor N Wainwright
Poster Session 2